Launched in 2009, Aging publishes papers of general interest and biological significance in all fields of aging research as well as topics beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, cancer, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR among others), and approaches to modulating these signaling pathways.


Oncotarget, launched in 2010, a primarily oncology-focused, peer-reviewed, open access journal. As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types and even tissues that can be viewed as targets relevant to cancer and other diseases as well. The term was introduced in the inaugural Editorial Introducing OncoTarget, by Mikhail Blagosklonny and Andrei Gudkov, https://doi.org/10.18632/oncotarget.101.


Launched in 2014, Oncoscience covers the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. Oncoscience also has a special mission: freeing researchers in oncology from publication costs. It is free for the readers and the authors.


Formerly a SAGE publication, Genes & Cancer was acquired in 2014 and covers all aspects of the structure and function of oncogenes, growth suppressor and apoptotic genes, including their roles in signal transduction and the mechanisms by which their expression and function are altered during tumor development. The Journal also invites papers in the areas of genomics, drug development and systems biology.